Intellipharmaceutics Reports Director Election Results
yahoo.com
news
2022-05-27 20:45:00

TORONTO, ON / ACCESSWIRE / May 27, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, reports, as required by TSX rules, that the five nominees, each of whom was an incumbent director of the Company, identified in the Management Information Circular dated April 12, 2022 (the "Circular") were elected as directors of the Company at the annual meeting of shareholders of the Company held today (the "Meeting").
